Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rhythm Pharmaceuticals buy JPMorgan Chase & Co.

Start price
€100.00
07.08.26 / 50%
Target price
€126.70
07.08.27
Performance (%)
0.00%
Price
€94.50
06.08.26
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ is currently unchanged from the start price. This prediction currently runs until 07.08.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Rhythm Pharmaceuticals 0.00%
iShares Core DAX® 2.573%
iShares Nasdaq 100 4.858%
iShares Nikkei 225® 5.590%
iShares S&P 500 3.250%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Rhythm Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 126.699
Change
Ends at 07.08.27

Rhythm Pharmaceuticals (RYTM) had its price target raised by JPMorgan Chase & Co. from $145.00 to $146.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat

Stopped prediction by JPMorgan_Chase___Co_ for Rhythm Pharmaceuticals

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€90.00
27.07.26
€127.17
27.07.27
5.00%
06.08.26